Who Will You Be Joining?
Here's a small sample of the attendees:
Board Director, Vaccentis AG
CEO, Lime Therapeutics
Co-founder & CBO, Deka Biosciences Inc.
President & CEO, Deka Biosciences Inc.
General Counsel, Deka Biosciences Inc.
VP, Technical Ops, Deka Biosciences Inc.
Associate Director BD, TreeFrog Therapeutics
Global Mfg & Supply BD&L Lead, Takeda
Alliance Management & BD Special Projects, Servier Pharmaceuticals
CBO, Tenza Bio
Executive Director, Business Development, Astria Therapeutics
VP Investments & Head of Corporate Development, Roivant
Partner, Good Health Capital
SVP, Head of Business Development, Orum Therapeutics
Business Development, Stealth
CEO, Nobias Therapeutics
Managing Director & Head of Biotech Private Equity, Ally Bridge Group
Managing Partner, Xpanse Bioventures
Associate Manager, Business Development, Astria Therapeutics
Global Head of Business Development, Rallybio
CEO, Saros Therapeutics
Executive Director, Corporate Dev & Strategy, Nimbus Therapeutics
Operating Partner, Playground Global
Senior Director, Business Development, Pathos AI
Chief Business Officer, Iyuda Therapeutics
Head of Business Development, InflaRx GmbH
Trustee, Alameda County Employees Retirement Association
VP, Commercial Strategy, Soleno Therapeutics
VP, Insights & Analytics, Ionis
Head of External Innovation, Life Sci Innovations, Danaher Corporation
Executive Director, Business Development, BlueSphere Bio
Chief Business Officer, Clasp Therapeutics
CEO, Canary Cure Therapeutics
Chief Business Officer, Strand Therapeutics
Director, Growth & Strategic Projects, Bausch and Lomb
Head of Commercial – HCP and Alliances, LinusBio
Associate Director, Corporate Development, Ardelyx Inc.
CEO, Kesin Pharma
Chief BD & Legal Officer, HanAll Biopharma
Chief Commercial Officer, Nuplicate Therapeutics
Where Strategy, Partnerships, and Growth Meet
Gain the insights you need to source, structure, and close high-value deals. Learn from experts in licensing, M&A, venture capital, and strategic alliances to elevate your BD approach.
Fierce Biotech Week 2026
May 12-14th
Conversations You Won't Want To Miss
Deals That Drive Discovery:
BD&L Leaders on Stage
Featured Speakers
Key Topics Covered for BD&L
Deal Drivers and Investment Priorities for Big Pharma and VCs
Operating Models for Search and Evaluation to Advance Innovation
IP Due Diligence Issues that can Derail a Deal
Dealmaking Trends and Insights for New Modalities and Technologies
Alternative Deal Constructs and Creative Financing
Negotiating and Evaluating Platform Deals
